SIRS-Lab Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 34

Employees

  • Latest Deal Type
  • M&A

SIRS-Lab General Information

Description

Developer of diagnostic technology intended to treat infections. The company specializes in detecting blood poisoning and sepsis and causative agent while monitoring specific immune responses for treatment information.

Contact Information

Website
sirslab.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Otto-Schott-Straße 15
  • 07745 Jena
  • Germany
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Acquirer
Corporate Office
  • Otto-Schott-Straße 15
  • 07745 Jena
  • Germany

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

SIRS-Lab Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 06-May-2013 Completed Bankruptcy: Admin/Reorg
3. Bankruptcy: Admin/Reorg 01-Jan-2013 Completed Bankruptcy: Admin/Reorg
2. Later Stage VC (Series A) 14-Dec-2006 $13.1M $13.1M Completed Product Development
1. Early Stage VC Completed Product Development
To view SIRS-Lab’s complete valuation and funding history, request access »

SIRS-Lab Patents

SIRS-Lab Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
DE-102011005235-A1 A method for identifying a subset of polynucleotides from an initial set of polynucleotides corresponding to the human genome for in vitro determination of a severity of the host response of a patient Active 08-Mar-2011
DE-102011005235-B4 A method for identifying a subset of polynucleotides from an initial set of polynucleotides corresponding to the human genome for in vitro determination of a severity of the host response of a patient Inactive 08-Mar-2011
WO-2012120026-A1 Method for identifying a subset of polynucleotides from an initial set of polynucleotides corresponding to the human genome for the in vitro determination of the severity of the host response of a patient Inactive 08-Mar-2011
DE-102009044085-A1 Method for in vitro detection and differentiation of pathophysiological conditions Inactive 23-Sep-2009
US-20110076685-A1 Method for in vitro detection and differentiation of pathophysiological conditions Inactive 23-Sep-2009 C12Q1/6883
To view SIRS-Lab’s complete patent history, request access »

SIRS-Lab Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

SIRS-Lab Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Affentranger Associates Venture Capital Minority
bm-t Beteiligungsmanagement Thuringen Growth/Expansion Minority
To view SIRS-Lab’s complete investors history, request access »

SIRS-Lab FAQs

  • When was SIRS-Lab founded?

    SIRS-Lab was founded in 2000.

  • Where is SIRS-Lab headquartered?

    SIRS-Lab is headquartered in Jena, Germany.

  • What is the size of SIRS-Lab?

    SIRS-Lab has 34 total employees.

  • What industry is SIRS-Lab in?

    SIRS-Lab’s primary industry is Diagnostic Equipment.

  • Is SIRS-Lab a private or public company?

    SIRS-Lab is a Private company.

  • What is SIRS-Lab’s current revenue?

    The current revenue for SIRS-Lab is .

  • How much funding has SIRS-Lab raised over time?

    SIRS-Lab has raised $13.1M.

  • Who are SIRS-Lab’s investors?

    Affentranger Associates and bm-t Beteiligungsmanagement Thuringen have invested in SIRS-Lab.

  • When was SIRS-Lab acquired?

    SIRS-Lab was acquired on 06-May-2013.

  • Who acquired SIRS-Lab?

    SIRS-Lab was acquired by Analytik Jena.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process